In last trading session, Day One Biopharmaceuticals Inc (NASDAQ:DAWN) saw 0.45 million shares changing hands with its beta currently measuring -1.53. Company’s recent per share
Day One Biopharmaceuticals Inc (NASDAQ:DAWN)’s traded shares stood at 1.78 million during the last session, with the company’s beta value hitting -1.52. At the close
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
